Mark J. Burk

Snap Bio, Inc. develops next-generation therapeutics. It discovers new therapeutics for oncology. The company is headquartered in San Diego, CA.

Lassogen, Inc. operates as a preclinical biotechnology company. It develops lasso peptides as a new therapeutic modality for diagnosing and treating intractable health challenges. The company was founded by Mark J. Burk, Douglas Mitchell, Tracy Handel and Kent Boles in 2019 and is headquartered in San Diego, CA.

Genomatica, Inc. designs and develops biotechnology products. It offers metabolic engineering for renewable production of commodity chemicals. The company was founded by Bernhard O. Palsson and Christophe H. Schilling in 1998 and is headquartered in San Diego, CA.

Diversa searches high and low for DNA. In its quest to develop new enzymes and other active biological compounds, the biotechnology company collects and catalogs the DNA of organisms in diverse environments (from manure piles to tropical islands). A variety of manufacturers license these compounds from the firm to develop or improve their products, which include detergents, oils, animal feeds, and pharmaceuticals. Diversa's products include enzymes for the oil and gas industry

Materia, Inc. manufactures catalysts and resins. It develops olefin metathesis catalyst technology. It offers design engineering, chemical process, catalyst screening solutions. The firm provides products to the automotive, industrial, oil and gas, pharmaceuticals, and renewable chemical industries. The company was founded by Michael A. Giardello and Christopher J. Cruce in 1998 and is headquartered in Pasadena, CA.

DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE.